Pexion is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 1 US drug patent filed in 2025. All patents are active. Details of Pexion’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US8859540 | Active | |
Exclusivity Information
Pexion holds 1 exclusivity out of which 1 has expired. Details of Pexion's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Dec 03, 2023 |
About Pexion
Pexion is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Pexion uses
Imepitoin as the active
ingredient.
Active Ingredient:
Pexion uses
Imepitoin as the active ingredient.
Check out other Drugs and Companies using
Imepitoin ingredient.